{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T11:49:32Z","timestamp":1785498572104,"version":"3.56.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":1576,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","fertstert.org","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.fertnstert.2017.10.021","type":"journal-article","created":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T06:15:56Z","timestamp":1515651356000},"page":"258-265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Antim\u00fcllerian hormone as a predictor of live birth following assisted reproduction: an analysis of 85,062 fresh and thawed cycles from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database for 2012\u20132013"],"prefix":"10.1016","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2500-9904","authenticated-orcid":false,"given":"Reshef","family":"Tal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Seifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan","family":"Wantman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oded","family":"Tal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2017.10.021_bib1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/humupd\/dmp036","article-title":"Anti-m\u00fcllerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)","volume":"16","author":"la Marca","year":"2010","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib2","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1530\/REP-09-0415","article-title":"Anti-m\u00fcllerian hormone and polycystic ovary syndrome: a mountain too high?","volume":"139","author":"Pellatt","year":"2010","journal-title":"Reproduction"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib3","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0015-0282(01)03201-0","article-title":"Early follicular serum m\u00fcllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles","volume":"77","author":"Seifer","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ajog.2017.02.027","article-title":"Ovarian reserve testing: a user\u2019s guide","volume":"217","author":"Tal","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib5","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.fertnstert.2007.02.014","article-title":"M\u00fcllerian inhibiting substance is an ovarian growth factor of emerging clinical significance","volume":"88","author":"Seifer","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib6","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/01.GME.0000123642.76105.6E","article-title":"Antim\u00fcllerian hormone is a promising predictor for the occurrence of the menopausal transition","volume":"11","author":"van Rooij","year":"2004","journal-title":"Menopause"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib7","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0015-0282(01)02993-4","article-title":"Antim\u00fcllerian hormone serum levels: a putative marker for ovarian aging","volume":"77","author":"de Vet","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib8","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1093\/humrep\/del291","article-title":"Serum anti-m\u00fcllerian hormone throughout the human menstrual cycle","volume":"21","author":"La Marca","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib9","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/humrep\/deh819","article-title":"Anti-m\u00fcllerian hormone concentrations in maternal serum during pregnancy","volume":"20","author":"La Marca","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib10","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ejogrb.2007.01.012","article-title":"Anti-m\u00fcllerian hormone levels during hormonal contraception in women with polycystic ovary syndrome","volume":"134","author":"Somunkiran","year":"2007","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib11","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/humupd\/dmq034","article-title":"AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis","volume":"17","author":"Broer","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib12","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.fertnstert.2015.10.004","volume":"105","author":"Seifer","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib13","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1093\/humrep\/dei203","article-title":"Dynamic assays of inhibin B, anti-m\u00fcllerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome","volume":"20","author":"Eldar-Geva","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib14","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1093\/humrep\/dem204","article-title":"Serum anti-m\u00fcllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles\u2014implications for individualization of therapy","volume":"22","author":"Nelson","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/humrep\/dei270","article-title":"M\u00fcllerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology","volume":"21","author":"Silberstein","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib16","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1210\/jc.2006-1053","article-title":"Anti-m\u00fcllerian hormone concentrations in the follicular fluid of the preovulatory follicle are predictive of the implantation potential of the ensuing embryo obtained by in\u00a0vitro fertilization","volume":"92","author":"Fanchin","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib17","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/humrep\/deh718","article-title":"Basal and stimulation day 5 anti-m\u00fcllerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist\u2013gonadotropin treatment","volume":"20","author":"Penarrubia","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib18","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.fertnstert.2005.09.019","article-title":"Early follicular antim\u00fcllerian hormone as an indicator of ovarian reserve","volume":"85","author":"Ficicioglu","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.fertnstert.2006.06.019","article-title":"Antim\u00fcllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in\u00a0vitro fertilization or intracyoplasmic sperm injection","volume":"87","author":"Smeenk","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib20","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1210\/jc.2012-3676","article-title":"Antim\u00fcllerian hormone levels are strongly associated with live-birth rates after assisted reproduction","volume":"98","author":"Brodin","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib21","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/humrep\/des101","article-title":"The value of anti-m\u00fcllerian hormone measurement in the long GnRH agonist protocol: association with ovarian response and gonadotrophin-dose adjustments","volume":"27","author":"Anckaert","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib22","doi-asserted-by":"crossref","first-page":"223.e1","DOI":"10.1016\/j.ajog.2011.04.035","article-title":"Use of in-cycle antim\u00fcllerian hormone levels to predict cycle outcome","volume":"205","author":"Blazar","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib23","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.fertnstert.2012.12.048","article-title":"Antim\u00fcllerian hormone in gonadotropin releasing\u2013hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients","volume":"99","author":"Arce","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib24","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s10815-012-9754-6","article-title":"Serum antim\u00fcllerian hormone, follicle stimulating hormone and antral follicle count measurement can not predict pregnancy rates in IVF\/ICSI cycles","volume":"29","author":"Sahmay","year":"2012","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib25","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s00404-011-1979-6","article-title":"Different serum anti-m\u00fcllerian hormone concentrations are associated with oocyte quality, embryo development parameters and IVF-ICSI outcomes","volume":"284","author":"Irez","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib26","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1016\/j.fertnstert.2010.04.067","article-title":"Anti-m\u00fcllerian hormone (AMH) defines, independent of age, low versus good live-birth chances in women with severely diminished ovarian reserve","volume":"94","author":"Gleicher","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib27","first-page":"715","article-title":"Antim\u00fcllerian hormone as a predictive factor in assisted reproductive technique of polycystic ovary syndrome patients","volume":"49","author":"Aleyasin","year":"2011","journal-title":"Acta Med Iran"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib28","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1016\/j.fertnstert.2009.12.002","article-title":"Serum antim\u00fcllerian hormone concentrations on day 3 of the in\u00a0vitro fertilization stimulation cycle are predictive of the fertilization, implantation, and pregnancy in polycystic ovary syndrome patients undergoing assisted reproduction","volume":"94","author":"Kaya","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib29","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10815-012-9726-x","article-title":"Correlation of serum Anti-m\u00fcllerian hormone concentrations on day 3 of the in\u00a0vitro fertilization stimulation cycle with assisted reproduction outcome in polycystic ovary syndrome patients","volume":"29","author":"Xi","year":"2012","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib30","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3109\/09513590.2013.769519","article-title":"Anti-m\u00fcllerian hormone and polycystic ovary syndrome: assessment of the clinical pregnancy rates in in\u00a0vitro fertilization patients","volume":"29","author":"Sahmay","year":"2013","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib31","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1016\/j.fertnstert.2011.03.071","article-title":"Random anti-m\u00fcllerian hormone (AMH) is a predictor of ovarian response in women with elevated baseline early follicular follicle-stimulating hormone levels","volume":"95","author":"Buyuk","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib32","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1479-828X.2011.01374.x","article-title":"Using anti-m\u00fcllerian hormone to identify a good prognosis group in women of advanced reproductive age","volume":"51","author":"Friden","year":"2011","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib33","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s10815-013-0077-z","article-title":"Determining an anti-m\u00fcllerian hormone cutoff level to predict clinical pregnancy following in\u00a0vitro fertilization in women with severely diminished ovarian reserve","volume":"30","author":"Merhi","year":"2013","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib34","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.gyobfe.2012.02.001","volume":"40","author":"Grzegorczyk-Martin","year":"2012","journal-title":"Gynecol Obstet Fertil"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib35","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.rbmo.2012.12.002","article-title":"Anti-m\u00fcllerian hormone as an independent predictor of twin versus singleton pregnancy in fresh cycles","volume":"26","author":"Tal","year":"2013","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib36","doi-asserted-by":"crossref","DOI":"10.1093\/humupd\/dmu003","article-title":"The predictive accuracy of anti-m\u00fcllerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature","author":"Iliodromiti","year":"2014","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib37","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.fertnstert.2014.09.041","article-title":"Antim\u00fcllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis","volume":"103","author":"Tal","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib38","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/humupd\/dmu027","article-title":"Fresh versus frozen embryo transfer: backing clinical decisions with scientific and clinical evidence","volume":"20","author":"Evans","year":"2014","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib39","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3109\/09513590.2014.899572","article-title":"Role of baseline antral follicle count and anti-m\u00fcllerian hormone in the index stimulation cycle of IVF treatment in predicting outcome of subsequent frozen-thawed embryo transfers","volume":"30","author":"Li","year":"2014","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib40","series-title":"2012 assisted reproductive technology success rates: national summary and fertility clinic reports","year":"2014"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib41","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.fertnstert.2008.08.110","article-title":"Variations in serum m\u00fcllerian inhibiting substance between white, black, and Hispanic women","volume":"92","author":"Seifer","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib42","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","article-title":"The meaning and use of the area under a receiver operating characteristic (ROC) curve","volume":"143","author":"Hanley","year":"1982","journal-title":"Radiology"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib43","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/humrep\/deu053","article-title":"Association between response to ovarian stimulation and miscarriage following IVF: an analysis of 124 351 IVF pregnancies","volume":"29","author":"Sunkara","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib44","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.fertnstert.2013.04.024","article-title":"Prediction of an excessive response in in\u00a0vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: an individual patient data meta-analysis","volume":"100","author":"Broer","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib45","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.fertnstert.2015.05.004","article-title":"Personalized prediction of live birth: Are we there yet?","volume":"104","author":"Seifer","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib46","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa1513873","article-title":"Fresh versus frozen embryos for infertility in the polycystic ovary syndrome","volume":"375","author":"Chen","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib47","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.fertnstert.2011.02.059","article-title":"Evidence of impaired endometrial receptivity after ovarian stimulation for in\u00a0vitro fertilization: a prospective randomized trial comparing fresh and frozen-thawed embryo transfers in high responders","volume":"96","author":"Shapiro","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib48","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.fertnstert.2015.06.024","article-title":"Two new automated, compared with two enzyme-linked immunosorbent, antim\u00fcllerian hormone assays","volume":"104","author":"Nelson","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib49","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1093\/humrep\/dev127","article-title":"Performance of the two new fully automated anti-m\u00fcllerian hormone immunoassays compared with the clinical standard assay","volume":"30","author":"van Helden","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib50","series-title":"FDA grants clearance to Roche\u2019s anti-m\u00fcllerian hormone test Elecsys","year":"2017"},{"key":"10.1016\/j.fertnstert.2017.10.021_bib51","series-title":"Antim\u00fcllerian hormone: biology, role in ovarian function and clinical significance","year":"2016"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001502821731991X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001502821731991X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T07:20:13Z","timestamp":1666509613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001502821731991X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S001502821731991X"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2017.10.021","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antim\u00fcllerian hormone as a predictor of live birth following assisted reproduction: an analysis of 85,062 fresh and thawed cycles from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database for 2012\u20132013","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2017.10.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92017 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}